Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
483
•First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy•June 14, 2019

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy – FDA 483, Jun 14, 2019

Record Details

From June 5-14, 2019, the FDA inspected First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy, a producer of sterile and non-sterile drug products in Mesa, AZ. The inspection, led by Bryan L Mcguckin, Investigator, identified twelve observations regarding deficiencies in their manufacturing processes and quality systems.

Key violations include inadequate validation of aseptic and sterilization processes, such as unvalidated sterilization equipment, lack of endotoxin challenge verification, and insufficient media fills and dynamic smoke studies (Observation 1). Aseptic processing areas were deficient in cleaning and disinfection, using non-sterile wipes and disinfectants without verified sporicidal activity (Observation 2). Environmental monitoring was insufficient, with only quarterly monitoring of ISO zones, pressure differentials, and personnel, and no alarm systems for air quality breaches (Observation 3). Airflow control in the ISO5 zone was compromised by a swaying curtain and exposed skin of the sterile drug tech (Observation 4).

The firm failed to investigate unexplained discrepancies, specifically viable air sample excursions in ISO7 and hazardous drug rooms (Observation 5). Personnel clothing was inappropriate for sterile production, with non-sterile attire and poor gowning practices observed (Observation 6). There was no written stability testing program for extended Beyond Use Dates (BUDs) of high-risk sterile products (Observation 7). Finished sterile drug products lacked sterility and pyrogen testing (Observation 8) and potency testing (Observation

Company
First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
Inspection date
June 14, 2019
Product type
Drugs
Office
Los Angeles District Office
Person
  • Bryan L. Mcguckin
View Company Profile

ID · fd55766d-bf7b-48cb-a7ef-83e1d9318232

Violation Codes2
21 CFR 21021 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
  • 483 - 2022-09-12September 12, 2022
  • STATE_REFERRAL_LETTER - 2022-09-01September 1, 2022
  • 483 - 2021-08-11August 11, 2021
  • WARNING_LETTER - 2019-06-14June 14, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.